The FDA has granted Breakthrough Therapy Designation for SkinTE based on key positive data from the Phase II study in Wagner1 DFUs highlighting ...
The Central California Blood Center has a new CEO to spearhead the nonprofit's mission of providing blood to area hospitals.
MAIA Biotechnology (MAIA) announced updated data from its THIO-101 pivotal Phase 2 clinical trial evaluating its lead clinical candidate, THIO, sequenced with Regeneron’s (REGN) immune ...
DUBLIN, Ireland, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions ...
Metsera is a clinical-stage biotechnology company developing injectable and oral treatments for obesity and related conditions, the filing shows. The company’s investors include affiliates of ...
The future of the Bay Area biotech firm Allakos was riding on one clinical trial, for a drug designed to treat the skin condition known as chronic spontaneous urticaria, or chronic hives.
Sam Altman, pictured at President Donald Trump's inauguration, is contributing to another round of funding for Retro Biosciences. © 2025 Fortune Media IP Limited ...
Only one traditional preclinical biotech—Metagenomi—went public last year, compared to around a quarter of the biotechs that IPOed in 2020 and 2021, according to Surti. About two-thirds of the ...
The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics revealing plans to go public while Hong Kong-listed Ascentage Pharma joins ...
Canada has long punched above its weight in life sciences and biotechnology, with many of the fundamental discoveries that underpin today’s important blockbuster drugs and therapeutic approaches ...
EU targets AI, biotech, green tech, advance materials sectors Draghi report said EU is falling behind US and China France, Trump push EU to cut business red tape EU plans include 25% reduction of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results